Tirzepatide is FDA-approved for type 2 diabetes management and for chronic weight management, also under established brand names
Because microdosing is an unofficial practice, there is no standardized way to do it
Berberine should not be described as a GLP-1 'activator' in the medicinal sense, as any effects on GLP-1 pathways appear to be indirect and considerably less potent than pharmaceutical GLP-1 therapies
It can increase the expression and function of tight junction proteins, such as occludin, claudins, and zonula occludens-1 (ZO-1), which are vital components of the gut barrier (105)
While the outcomes of these early test cases will not be binding on other claims, they will be closely watched and may help the parties negotiate GLP-1 settlements to resolve large numbers of lawsuits in the future
doi:10.2337/diabetes.52.5.1147 197